Vbeam® Prima Laser

April 22, 2019

Brought to you by:

Brought to you by:

Podcasts:

 

Treating Inflammatory Acne & Surgical Scars with the new Vbeam Prima Platform

 

Presented by:

Jill S. Waibel, MD


 

 


Jill S. Waibel, MD, a board-certified dermatologist specializing in general dermatology, cutaneous laser surgery and cosmetic dermatology for adults and children, is a world-recognized leader in dermatologic laser surgery and lectures across the world to train other physicians.

 

 

Gilly S. Munavalli, MD, MHS, FACMS, describes his successful transition to the Vbeam Prima Laser for treating both small and prominent vascular blood vessels.

 

Presented by:

Gilly S. Munavalli, MD, MHS, FACMS


Charlotte, NC
Medical Director and Founder,
Dermatology, Laser & Vein Specialist of the Carolinas, PLLC
Assistant Professor of Dermatology ,Wake Forest University.
Winston Salem, NC USA

 

 


 
 

Dr. Munavalli, a native of North Carolina, is medical director and founder of DLVSC. He trained in Dermatology at Emory University, Dermatologic Surgery fellowships in Mohs Micrographic Surgery (for the treatment of facial skin cancers) , Cutaneous Oncology, Facial Reconstruction, Cosmetic Surgery and Laser Surgery at the University of California-San Francisco.

He also completed a Phlebology and advanced laser surgery fellowship at the Maryland Laser, Skin, and Vein Institute. He received his Bachelor of Science from the University of North Carolina-Chapel Hill, Masters of Health Science from the Johns Hopkins University School of Public Health, Doctorate of Medicine from Morehouse Medical School in Atlanta, Georgia, followed by internship training at the Mayo Clinic. Dr. Munavalli received his Board Certification in Dermatology in 2002.

Dr. Munavalli has published over 50 peer-reviewed journal articles and book chapters. His medical memberships include the Board certification and member of the American Academy of Dermatology. He is a member and fellow of the American College of Mohs Micrographic and Cutaneous Oncology, American Society for Dermatologic Surgery, American Society for Laser Medicine and Surgery, and the American College of Phlebology. His current affiliations include Assistant Professor of Dermatology at the Wake Forest University Department of Dermatology. Previously , he spent 4 years on the clinical faculty of Dermatology at Johns Hopkins School of Medicine, in Baltimore, MD.

 

In the second of a two-part series, Eric Bernstein, MD, MSE, discusses a study of patients with poikiloderma of civatte who were treated with the Vbeam Prima Laser

 

Presented by:

Eric F. Bernstein, M.D., M.S.E


 

 


 
 

Eric F. Bernstein earned a Bachelor of Science degree from Duke University in 1981 graduating Phi Beta Kappa, summa cum laude with distinction in his major. He then earned his degree in medicine from Yale University School of Medicine in 1986 where he served as Banner Bearer at commencement exercises and class president. He completed a fellowship at the NCI at NIH, investigating PDT and cytokines for wound healing. Dr. Bernstein served as Associate Professor in the Department of Dermatology and Cutaneous Biology at Jefferson Medical College. There he directed a photobiology laboratory and founded the Laser Surgery Center. Dr. Bernstein’s research focused on the molecular causes of skin photoaging and its repair. He also earned an M.S.E. in Management of Technology from the School of Engineering and Applied Science at the University of Pennsylvania, co-administered by the Wharton School.

Dr. Bernstein founded DakDak Photoaging Technologies receiving an SBIR grant from NIH to commercialize a molecular model of skin photoaging. This company was sold to Charles River Laboratories, a public biotechnology company. Dr. Bernstein is also founder/director of the Main Line Center for Laser Surgery. Dr. Bernstein is president of the ASLMS, and serves on numerous laser company scientific advisory boards, and was a Director for Candela Corporation and now heads their Medical Advisory Board. Dr. Bernstein has also served as a director for Once Again Me, Inc., Intellectual Light, Inc., Chairman of Freedom-2 Inc., and is founder and CEO of Alethia, LLC, home of LaseResults skincare, and co-founded American Medical Media, Inc. and Call Compass, LLC. He has consulted for numerous cosmetic companies including Estée Lauder, focusing on the La Mer and Lauder brands, as well as NeoStrata, Avon, the biotech company SIRNA and others.

Dr. Bernstein currently serves as volunteer faculty at the University of Pennsylvania and Temple University in the Department of Dermatology as a Clinical Professor. He has authored over 100 peer-reviewed articles and review articles or book chapters and given more than 300 presentations at scientific meetings. He has been issued over a dozen U.S. and numerous international patents. In addition, Dr. Bernstein has been cited in the popular press appearing on CNN, 20/20, NBC, NPR, CBS and Fox news, and has been featured by the Associated Press, Allure, Oprah Magazine, Harper’s Bazaar and many other outlets.

 

 

Shining New Light on the Treatment of Rosacea with the New Vbeam Prima Laser

 

Presented by:

Eric F. Bernstein, M.D., M.S.E


 

 


 
 

Eric F. Bernstein earned a Bachelor of Science degree from Duke University in 1981 graduating Phi Beta Kappa, summa cum laude with distinction in his major. He then earned his degree in medicine from Yale University School of Medicine in 1986 where he served as Banner Bearer at commencement exercises and class president. He completed a fellowship at the NCI at NIH, investigating PDT and cytokines for wound healing. Dr. Bernstein served as Associate Professor in the Department of Dermatology and Cutaneous Biology at Jefferson Medical College. There he directed a photobiology laboratory and founded the Laser Surgery Center. Dr. Bernstein’s research focused on the molecular causes of skin photoaging and its repair. He also earned an M.S.E. in Management of Technology from the School of Engineering and Applied Science at the University of Pennsylvania, co-administered by the Wharton School.

Dr. Bernstein founded DakDak Photoaging Technologies receiving an SBIR grant from NIH to commercialize a molecular model of skin photoaging. This company was sold to Charles River Laboratories, a public biotechnology company. Dr. Bernstein is also founder/director of the Main Line Center for Laser Surgery. Dr. Bernstein is president of the ASLMS, and serves on numerous laser company scientific advisory boards, and was a Director for Candela Corporation and now heads their Medical Advisory Board. Dr. Bernstein has also served as a director for Once Again Me, Inc., Intellectual Light, Inc., Chairman of Freedom-2 Inc., and is founder and CEO of Alethia, LLC, home of LaseResults skincare, and co-founded American Medical Media, Inc. and Call Compass, LLC. He has consulted for numerous cosmetic companies including Estée Lauder, focusing on the La Mer and Lauder brands, as well as NeoStrata, Avon, the biotech company SIRNA and others.

Dr. Bernstein currently serves as volunteer faculty at the University of Pennsylvania and Temple University in the Department of Dermatology as a Clinical Professor. He has authored over 100 peer-reviewed articles and review articles or book chapters and given more than 300 presentations at scientific meetings. He has been issued over a dozen U.S. and numerous international patents. In addition, Dr. Bernstein has been cited in the popular press appearing on CNN, 20/20, NBC, NPR, CBS and Fox news, and has been featured by the Associated Press, Allure, Oprah Magazine, Harper’s Bazaar and many other outlets.

©2019 Candela Corporation. This material contains registered and unregistered trademarks, trade-names, service marks and brand names of Candela Corporation and its affiliates, including Candela, Vbeam, Vbeam Perfecta and Vbeam Prima. All other trademarks are the property of their respective owners. All rights reserved.